Jorge Lascano

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor”.

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

Annals of the American Thoracic Society(2025)10.1513/annalsats.202507-817oc

N/A

0.396DataRank · unranked

8 citations

T. Spencer Poore, Brandie D. Wagner, Jing Xie, Sonya L. Heltshe, Mary Cross +65 more

Lung Inflammation in Alpha-1-Antitrypsin Deficient Individuals with Normal Lung Function

Research Square(2022)10.21203/rs.3.rs-2378966/v1

N/A

0DataRank · unranked

2 citations

Nazli Khodayari, Jorge Lascano, E. Leonard Riley, Mark Brantly, Nurdan Köktürk

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.04.008

N/A

0DataRank · unranked

144 citations

Jonathan B. Zuckerman, Daniel Dorgan, Jorge Lascano, Karen McCoy, Manu Jain +15 more

Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function

Respiratory Research(2023)10.1186/s12931-023-02343-3

N/A

0DataRank · unranked

31 citations

Nazli Khodayari, Jorge Lascano, E. Leonard Riley, Mark Brantly, Nurdan Köktürk